Table 3. Changes in blood parameters at baseline and after 12 weeks. Values are mean (± SEM). |
|
Walking Group
(n = 14) |
Control Group
(n = 14) |
P -value
(time, interaction) |
| Triacylglycerol (mmol/L) |
Baseline |
1.05 (.10) |
1.11 (.12) |
.558, 1.000 |
| 12 weeks |
1.10 (.149 |
1.16 (.19) |
| TC (mmol/L) |
Baseline |
5.84 (.21) |
5.67 (.19) |
.979, .189 |
| 12 weeks |
5.93 (.24) |
5.58 (.17) |
| HDL-C (mmol/L) |
Baseline |
1.79 (.10) |
1.64 (.10) |
.001, .049 |
| 12 weeks |
1.93 (.10) * |
1.69 (.10) |
| LDL-C (mmol/L) |
Baseline |
3.40 (.18) |
3.36 (.17) |
.215, .603 |
| 12 weeks |
3.34 (.17) |
3.23 (.17) |
| Glucose (mmol/L) |
Baseline |
5.20 (.24) |
5.10 (.69) |
.460, .849 |
| 12 weeks |
5.15 (.15) |
5.01 (.63) |
| Insulin (pmol/L) |
Baseline |
23.2 (3.1) |
23.7 (3.2) |
.155, .687 |
| 12 weeks |
26.8 (3.3) |
30.2 (8.3) |
| HbA1c (%) |
Baseline |
5.12 (.85) |
5.00 (.03) |
.294, .065 |
| 12 weeks |
5.22 (.12) |
4.97 (.37) |
| sE-selectin (ng/ml) |
Baseline |
37.0 (3.1) |
41.2 (3.2) |
.002, .231 |
| 12 weeks |
34.8 (3.6) |
36.6 (2.8) * |
| sVCAM-1 (ng/ml) |
Baseline |
529 (32) |
608 (40) |
.001, .878 |
| 12 weeks |
435 (33) ** |
518 (37) ** |
| C-peptide (pmol/L) |
Baseline |
368 (32) |
410 (34) |
.629, .357 |
| 12 weeks |
387 (27) |
404 (36) |
| Oxidised LDL (U/L) |
Baseline |
53.8 (5.5) |
51.2 (5.7) |
.075, .743 |
| 12 weeks |
46.0 (3.7) |
45.8 (4.4) |
|
TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; sE-selectin, soluble E-selectin; sVCAM-1, soluble vascular adhesion molecule-1; Oxidised LDL, Oxidised low-density lipoprotein. |
* Significantly different from the baseline value in the same group (Paired Student`s t-test p < 0.05) |
** Significantly different from the baseline value in the same group (Paired Student`s t-test p < 0.001) |
|